STRS Ohio’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154K Buy
3,500
+600
+21% +$24K ﹤0.01% 1714
2026
Q1
$116K Buy
+2,900
New +$111K ﹤0.01% 1717
2025
Q3
Sell
-2,300
Closed -$39.9K 2309
2025
Q2
$39.9K Buy
+2,300
New +$30.1K ﹤0.01% 2058

Other funds holding SION

STRS Ohio's SION Position: Q2 2026 in Review

STRS Ohio increased its Sionna Therapeutics (SION) stake by 21% in Q2 2026, buying an estimated $24K and bringing the position to 3,500 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1714.

STRS Ohio first reported a position in SION in Q2 2025 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • STRS Ohio held 3,500 shares of Sionna Therapeutics worth $154K as of Q2 2026.
  • STRS Ohio bought 600 Sionna Therapeutics shares in Q2 2026, an estimated $24K.
  • Sionna Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1714 holding.
  • STRS Ohio first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 17 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.